Plain-English translation of NCT06902805 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing whether a medication called (Botox) injected directly into the thumb joint can help reduce pain from thumb arthritis. Participants will receive either two doses of this medication, one dose plus a placebo injection, or two placebo injections — all while wearing a custom-made rigid splint. The goal is to see if this treatment, given twice over several months, provides long-lasting pain relief.
Thumb arthritis is common and causes significant pain and difficulty with hand activities. Current treatments have only modest effects. Early research suggests that this medication might help reduce pain by working on the nerves in the joint, but doctors need a larger, well-designed study to confirm it works, understand how long the benefits last, and make sure it's safe.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to one of three groups: two real medication injections, one real and one placebo injection, or two placebo injections. All participants will also receive a custom-made rigid splint to wear. The injections will be guided by ultrasound to ensure accuracy. You will visit the clinic for injections and follow-up visits over several months to allow researchers to track your pain levels and how well your hand is functioning. The trial will measure whether the treatment reduces your pain and improves your ability to use your hand in daily activities.
AI-generated summary from trial data · Jun 27, 2026 · Not medical advice
France